Abstract

The glucagon-like peptide-1 receptor (GLP1R) is a class B G protein-coupled receptor (GPCR) involved in glucose homeostasis and food intake. GLP1R agonists (GLP1RA) are widely used in the treatment of diabetes and obesity, yet visualizing the endogenous localization, organization and dynamics of a GPCR has so far remained out of reach. In the present study, we generate mice harboring an enzyme self-label genome-edited into the endogenous Glp1r locus. We also rationally design and test various fluorescent dyes, spanning cyan to far-red wavelengths, for labeling performance in tissue. By combining these technologies, we show that endogenous GLP1R can be specifically and sensitively detected in primary tissue using multiple colors. Longitudinal analysis of GLP1R dynamics reveals heterogeneous recruitment of neighboring cell subpopulations into signaling and trafficking, with differences observed between GLP1RA classes and dual agonists. At the nanoscopic level, GLP1Rs are found to possess higher organization, undergoing GLP1RA-dependent membrane diffusion. Together, these results show the utility of enzyme self-labels for visualization and interrogation of endogenous proteins, and provide insight into the biology of a class B GPCR in primary cells and tissue.

Visualizing endogenous GPCRs is challenging. Here the authors generate mice with an enzyme self-label genome-edited into the endogenous glucagon-like peptide-1 receptor locus, design fluorescent dyes for specific labelling in complex tissue, and reveal tissue-level organisation and dynamics of an endogenous class B GPCR.

Details

Title
Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling
Author
Ast, Julia 1   VIAFID ORCID Logo  ; Nasteska, Daniela 1 ; Fine, Nicholas H. F. 1   VIAFID ORCID Logo  ; Nieves, Daniel J. 2   VIAFID ORCID Logo  ; Koszegi, Zsombor 1   VIAFID ORCID Logo  ; Lanoiselée, Yann 1 ; Cuozzo, Federica 1   VIAFID ORCID Logo  ; Viloria, Katrina 1 ; Bacon, Andrea 3 ; Luu, Nguyet T. 4 ; Newsome, Philip N. 4 ; Calebiro, Davide 1   VIAFID ORCID Logo  ; Owen, Dylan M. 2   VIAFID ORCID Logo  ; Broichhagen, Johannes 5   VIAFID ORCID Logo  ; Hodson, David J. 6   VIAFID ORCID Logo 

 University of Birmingham, Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 University of Birmingham, Institute for Immunology and Immunotherapy, and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 University of Birmingham, Genome Editing Facility, Technology Hub, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 University of Birmingham, National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); University of Birmingham, Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany (GRID:grid.418832.4) (ISNI:0000 0001 0610 524X) 
 University of Birmingham, Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
Pages
301
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2766596740
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.